CRN | WholeFoods Magazine

FDA Releases Dietary Supplement Ingredient Directory; Industry Reacts

“This sort of communication, without providing any new information for stakeholders, will reinforce industry misgivings about giving the agency even more authority," said AHPA's Michael McGuffin.

March 15, 2023

Maggie Jaqua

The FDA has released its new Dietary Supplement Ingredient Directory, which it says is intended to be "a one stop shop of ingredient information that was previously found on different FDA webpages."

Industry Groups Spotlight Natural Products Industry Week

March 3, 2023

WholeFoods Magazine Staff

Natural products industry trade groups joined together to acknowledge Natural Products Industry Week.

Organic fruit, vegetables, healthy drink, and nutrition supplements.

Industry Groups Submit Comment to FDA on Proposed Rule for “Healthy” Claims

The rule would update the “healthy” implied nutrient content claim

March 2, 2023

Maggie Jaqua

The Council for Responsible Nutrition (CRN) and the American Herbal Products Association (AHPA) were among those who submitted comments to FDA on its proposed rule to update “healthy” implied nutrient content claims.

FDA: Existing Regulatory Frameworks for Foods & Supplements Not Appropriate for CBD

January 26, 2023

Maggie Jaqua

Silver Spring, MD—There needs to be new regulatory pathway for cannabidiol (CBD) that balances consumers’ desire for access to CBD products with regulatory oversight that can manage risks. That's the conclusion the U.S. Food and Drug Administration (FDA) has reached after convening an internal working group to explore potential regulatory...

Mandatory Product Listing for Dietary Supplements Not Included in FY23 U.S. Spending Bill; Industry Reacts

December 27, 2022

Maggie Jaqua

Article updated on January 4, 2023, with additional industry response. On December 23, 2022, the House passed the Consolidated Appropriations Act of 2023 (H.R.2617), an omnibus spending bill consisting of all 12 fiscal year 2023 appropriations bills. It provides $1.7 trillion in discretionary resources across the fiscal year 2023 appropriations...

CRN Celebrates 50 Years!

December 27, 2022

Maggie Jaqua

Washington, D.C.—Cheers to the Council for Responsible Nutrition (CRN) for marking its a major milestone! Founded in 1973, the organization has now played a role in the growth of the dietary supplement industry for 50 years. Throughout 2023, CRN will be reflecting on its history and looking ahead to how the trade...

CRN & ASNF Program for Scholars Honorees Benefit from Access to Nutrition Science Symposium

December 5, 2022

Maggie Jaqua

Washington, D.C.—In their latest efforts to support educational opportunities for the next generation of nutrition scientists and practitioners, the Council for Responsible Nutrition (CRN) and American Society for Nutrition Foundation (ASNF) have partnered to present the CRN and ASNF Program for Scholars (CAPS) Award. Launched in 2021, the program provides selected...

β-NMN Is Not a Dietary Supplement? CRN Responds

November 29, 2022

Maggie Jaqua

Following a notification by the Food and Drug Administration (FDA) that beta-nicotinamide mononucleotide (β-NMN) is not a legal dietary ingredient, Council for Responsible Nutrition (CRN) President and CEO Steve Mister outlined the problems. “CRN is alarmed that, once again, FDA changed its position on whether an ingredient—in this case, beta-nicotinamide mononucleotide (β-NMN)—can...

People News: December 2022

November 29, 2022

WholeFoods Magazine Staff

Anissa Medina has joined the American Herbal Products Association (AHPA) as Education & Events Manager. Medina has served as Vice President for State Lobbying for the U.S. Hemp Roundtable. In her new role, she will manage and strengthen AHPA’s educational programming on regulatory compliance, technical issues, and other topics in...

Industry Reacts to Study "Wrongly" Comparing Supplements to Rx

November 28, 2022

Maggie Jaqua

Washington, D.C.—A recent Cleveland Clinic trial compared common dietary supplements to a low-dose cholesterol-lowering medication (a statin). The study was funded by AstraZeneca, which markets Rosuvastatin. Researchers looked at the funder’s low-dose statin, placebo, and six supplements—fish oil, cinnamon, garlic, turmeric, plant sterols, and red yeast rice—over a four-week period for impact on low-density...